高血清同型半胱氨酸与严重慢性静脉疾病的关联
该回顾性研究纳入582例原发性慢性静脉疾病患者,按CEAP分级分为C1-C3组与C4-C6组。结果显示C1-C3组同型半胱氨酸中位数高于C4-C6组(15.40 μmol/L vs. 14.05 μmol/L,P<0.01),但logistic回归显示同型半胱氨酸并非独立危险因素,而年龄和女性与更严重分期相关。
要点
- 同型半胱氨酸水平在各CEAP分级间差异有统计学意义。
- C1-C3组同型半胱氨酸中位数高于C4-C6组(15.40 vs. 14.05 μmol/L,P<0.01)。
- 同型半胱氨酸非严重慢性静脉疾病的独立危险因素,年龄和女性与更严重分期相关。
核心结论
- 较高同型半胱氨酸水平与更严重慢性静脉疾病分期相关,但并非独立危险因素。
- 高龄和女性是基于logistic回归分析的慢性静脉疾病发展危险因素。
研究设计与样本
- 回顾性收集582例诊断为原发性慢性静脉疾病患者的临床数据。
- 采用CEAP分类系统评估疾病严重程度,将患者分为C1-C3组和C4-C6组。
- 使用秩和检验和logistic回归分析同型半胱氨酸水平与疾病严重程度的关联。
主要发现
- 各CEAP分级间同型半胱氨酸水平差异有统计学意义。
- C1-C3组同型半胱氨酸中位数高于C4-C6组(15.40 μmol/L vs. 14.05 μmol/L,P<0.01)。
- 二元logistic回归显示同型半胱氨酸各区间与更严重分期无统计学显著性:11.00-14.75 μmol/L(OR 0.66,95% CI 0.40-1.11,P=0.12)、14.75-20.38 μmol/L(OR 0.97,95% CI 0.59-1.69,P=0.89)、≥20.38 μmol/L(OR 0.67,95% CI 0.41-1.10,P=0.11)。
- 年龄(OR 1.03,95% CI 1.01-1.04,P<0.01)和女性(OR 0.41,95% CI 0.28-0.59,P<0.01)与更严重慢性静脉疾病分期相关。
临床怎么用
- 评估慢性静脉疾病严重程度时,可将高龄和女性作为风险分层参考因素。
- 同型半胱氨酸水平不宜单独用于判断慢性静脉疾病严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Homocysteine (Hcy) is considered as a modifiable risk factor for vascular disease. This study was aimed to explore the association between serum concentration and the severity of primary chronic venous disease (CVD). METHODS: Clinical data of 582 patients diagnosed with primary CVD were collected and analyzed retrospectively. The Clinical Etiology Anatomy Pathophysiology classification system was used to grade the severity of chronic venous disease. Patients were divided into 2 groups (group A: C1-C3; group B: C4-C6). The association between serum homocysteine levels and the severity of primary chronic venous disease was investigated using rank sum test and logistic regression. RESULTS: The difference between the level of homocysteine in each grade has statistical significance. Group A has higher median Hcy concentrations than Group B (15.40 μmol/L vs. 14.05 μmol/L, P< 0.01). Further binary logistic regression showed no statistical significance among the level of Hcy (11.00-14.75 μmol/L [OR 0.66, 95% CI 0.40-1.11, P= 0.12], 14.75-20.38μmol/L [OR 0.97, 95% CI 0.59-1.69, P = 0.89], ≥20.38 μmol/L [OR 0.67, 95% CI 0.41-1.10, P = 0.11]), but age (OR 1.03, 95% CI 1.01-1.04, P< 0.01) and female (OR 0.41, 95% CI 0.28-0.59, P< 0.01) are associated with more severe stages of CVD. CONCLUSIONS: Higher level of Hcy is associated with more severe stages of CVD, but it not an independent risk factor. However, Advanced age and female are risk factors for CVD development based on logistic regression analysis.
引用
- Gao H, Xu H, Zhang J, et al. Association of High Serum Homocysteine Levels and Severe Chronic Venous Disease. Ann Vasc Surg. 2021. PMID: 33549775. doi:10.1016/j.avsg.2020.12.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。